Annual banned-substance review: analytical approaches in human sports drug testing - [2015-2016]

Annual banned-substance review: analytical approaches in human sports drug testing / Mario Thevis, Tiia Kuuranne, Hans Geyer, Wolhelm Schänzer. - (Drug testing and analysis 9 (2017) 1 (January) : p. 6-29)

  • PMID: 27885819
  • DOI: 10.1002/dta.2139


Contents:

  • Introduction
  • Non-approved substances
  • Anabolic agents
    • Anabolic-androgenic steroids
    • Iitial testing procedures – multi-analyte screening methods and alternative chromatographic- mass spectrometric techniques
    • Initial testing procedures – metabolism studies and new target analytes
      • Steroid profiling
      • Alternative test methods and approaches
      • Other anabolic agents
    • Peptide hormones, growth factors and related subsances
      • Hyoxia-iducible factor stabilizers and activators
      • Growth hormone
      • Corticotrophins, insulin-like growth factor-1 (IGF-1), and other growth or releasing factors
    • Beta-2-agonists
    • Hormone and metabolic modulators
  • Diuretics and other masking agents
  • Stimulants
  • Narcotics and glucocorticoids
  • Manipulation of blood and blood components
  • Chemical and physical manipulation
  • Gene doping
  • Conclusion
  • References

 Abstract

There has been an immense amount of visibility of doping issues on the international stage over the past 12 months with the complexity of doping controls reiterated on various occasions. Hence, analytical test methods continuously being updated, expanded, and improved to provide specific, sensitive, and comprehensive test results in line with the World Anti-Doping Agency's (WADA) 2016 Prohibited List represent one of several critical cornerstones of doping controls. This enterprise necessitates expediting the (combined) exploitation of newly generated information on novel and/or superior target analytes for sports drug testing assays, drug elimination profiles, alternative test matrices, and recent advances in instrumental developments. This paper is a continuation of the series of annual banned-substance reviews appraising the literature published between October 2015 and September 2016 concerning human sports drug testing in the context of WADA's 2016 Prohibited List.

Original document

Parameters

Science
Review
Date
25 November 2016
People
Geyer, Hans
Kuuranne, Tiia
Schänzer, Wilhelm
Thevis, Mario
Country
Germany
Switzerland
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
WADA Code, Guidelines, Protocols, Rules & Regulations
WADA Prohibited List International Standard
Other organisations
Centre Hospitalier Universitaire Vaudois (CHUV) - Lausanne University Hospital
Deutsche Sporthochschule Köln (DSHS) - German Sport University Cologne
European Monitoring Center for Emerging Doping Agents (EuMoCEDA)
Laboratories
Cologne, Germany: Institute of Biochemistry - German Sport University Cologne
Lausanne, Switzerland: Laboratoire Suisse d’Analyse du Dopage
Analytical aspects
Testing method development
Doping classes
M1. Manipulation Of Blood And Blood Components
M2. Chemical And Physical Manipulation
M3. Gene And Cell Doping
P1. Beta-Blockers
S0. Non-Approved Substances
S1. Anabolic Agents
S2. Peptide Hormones, Growth Factors
S3. Beta-2 Agonists
S4. Hormone And Metabolic Modulators
S5. Diuretics and Other Masking Agents
S6. Stimulants
S7. Narcotics
S9. Glucocorticosteroids
Various
Doping control
Document category
Scientific article
Document type
Pdf file
Date generated
16 January 2017
Date of last modification
23 November 2022
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin